Zobrazeno 1 - 10
of 87
pro vyhledávání: '"high dose rate interstitial brachytherapy"'
Publikováno v:
Current Oncology, Vol 29, Iss 8, Pp 5262-5277 (2022)
The recurrence rate of cervical cancer after primary treatment can reach 60%, and a poor prognosis is reported in most cases. Treatment options for the recurrence of cervical cancer mainly depend on the prior treatment regimen and the location of rec
Externí odkaz:
https://doaj.org/article/2a9ed018301740c1bb89fb498993be63
Autor:
Toru Matsugasumi, Koji Masui, Kaori Yamada, Sho Watanabe, Koji Okihara, Nana Kozawa, Yasuhiro Yamada, Hideya Yamazaki, Kei Yamada, Osamu Ukimura
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 854-860 (2021)
Prostate squamous cell carcinoma (pSCC) rarely develops as a secondary cancer after treatment with low-dose-rate brachytherapy (LDR-BT). There is no established effective treatment for the disease condition. Herein, we present a 78-year-old man who d
Externí odkaz:
https://doaj.org/article/9e1218652e354894b1c7308d57e7462a
Autor:
Koji Masui, Hideya Yamazaki, Gen Suzuki, Daisuke Shimizu, Tadashi Takenaka, Yasuhiro Yamada, Koji Okihara, Yoshiaki Kuriu, Kei Yamada
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 12, Iss 2, Pp 188-192 (2020)
High-dose-rate interstitial brachytherapy (HDR-ISBT) is widely used for the treatment of pelvic tumors. However, there are a few reports on complications of applicator implantation in HDR-ISBT. We describe a case of small bowel perforation caused by
Externí odkaz:
https://doaj.org/article/1a48e76bf79248bc9f8655e1900540ec
Autor:
Ken Yoshida, Tadayuki Kotsuma, Hironori Akiyama, Hideya Yamazaki, Tadashi Takenaka, Koji Masui, Yutaka Tsujimoto, Naoya Murakami, Yasuo Uesugi, Taiju Shimbo, Nobuhiko Yoshikawa, Hiroto Yoshioka, Mio Nakata, Takumi Arika, Yuji Takaoka, Eiichi Tanaka, Nikolaos Tselis
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 11, Iss 6, Pp 573-578 (2019)
Externí odkaz:
https://doaj.org/article/9b001bea99d14ea5a4b327a7da1d6d2f
Autor:
Yoshiaki Takagawa, Naoya Murakami, Shigenobu Suzuki, Fumihiko Matsumoto, Seiichi Yoshimoto, Jun Itami
Publikováno v:
Clinical Case Reports, Vol 7, Iss 10, Pp 1844-1848 (2019)
Abstract High‐dose‐rate interstitial brachytherapy (HDR‐ISBT) achieved excellent local control of the bulky sebaceous carcinoma of the eyelid. However, we must pay attention to dose of eyelid and cornea about late toxicity of HDR‐ISBT.
Externí odkaz:
https://doaj.org/article/6faf121672dd422a9438f35091e7218d
Autor:
Bei Yanping, Naoya Murakami, Satoshi Shima, Kana Takahashi, Koji Inaba, Kae Okuma, Hiroshi Igaki, Yuko Nakayama, Jun Itami
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 11, Iss 4, Pp 343-348 (2019)
Treatment options for patients with recurrent rectal cancer in pelvis represent a significant challenge because the balance of efficiency and toxicity needs to be pursued. This case report illustrates a treatment effect of image-guided high-dose-rate
Externí odkaz:
https://doaj.org/article/9a1981e8a90849ba9d5986ff734384d0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kaori Yamada, Kei Yamada, Yasuhiro Yamada, Nana Kozawa, Hideya Yamazaki, Sho Watanabe, Toru Matsugasumi, Koji Masui, Koji Okihara, Osamu Ukimura
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 2, Pp 854-860 (2021)
Case Reports in Oncology, Vol 14, Iss 2, Pp 854-860 (2021)
Prostate squamous cell carcinoma (pSCC) rarely develops as a secondary cancer after treatment with low-dose-rate brachytherapy (LDR-BT). There is no established effective treatment for the disease condition. Herein, we present a 78-year-old man who d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::751439e10521db4c1fd410ee1843144a
http://europepmc.org/articles/PMC8255723
http://europepmc.org/articles/PMC8255723
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.